Nature Medicine
Close windowclose window
Figure 1

Nature Medicine  9, 448 - 452 (2003)
Published online: 17 March 2003; | doi:10.1038/nm840

Neuropathology of human Alzheimer disease after immunization with amyloid-bold beta peptide: a case report

James A.R. Nicoll, David Wilkinson, Clive Holmes, Phil Steart, Hannah Markham & Roy O. Weller
 
Fig 1 full size
Figure 1. Distribution and quantitation of Abeta pathology.
a, MRI scan at the time of acute illness, showing widespread signal alteration in cerebral white matter. b, Corresponding granular change in cerebral white matter seen in a coronal slice of the cerebral hemispheres at post-mortem examination. c, Patches of Abeta plaques largely restricted to deep cortical laminae in the cingulate gyrus and medial frontal gyrus (immunized case). d, Absence of Abeta plaques from parietal neocortex of the immunized case, with persistent vascular amyloid (CAA). e and f, Relatively uniform distribution of Abeta plaques in corresponding regions of cerebral cortex in unimmunized AD. g and h, Quantitative image analysis showing plaque density (plaques/mm2; g) and Abeta load (h). For the immunized case in the medial frontal gyrus (c), values were within the range of unimmunized Alzheimer's disease. In contrast, the plaque density and Abeta load of the immunized case was lower than in unimmunized AD in the cingulate gyrus, and the inferior, middle and superior temporal gyri. , immunized case; open shapes, 7 individual unimmunized AD cases.

 
Next 
Close windowclose window
©2007 Nature Publishing Group | Privacy policy